Buying ‘Political Intelligence’ Can Pay Off Big for Wall Street
Marwood Group provides investors with insights on likely federal government actions; one call—saying an Amylin Pharmaceuticals diabetes drug faced headwinds at the FDA—has drawn the SEC’s attention.






